SeaCrest Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$214K Sell
2,731
-1,250
-31% -$97.8K 0.02% 559
2025
Q1
$289K Sell
3,981
-150
-4% -$10.9K 0.03% 488
2024
Q4
$306K Sell
4,131
-11
-0.3% -$814 0.03% 485
2024
Q3
$273K Buy
4,142
+11
+0.3% +$726 0.03% 516
2024
Q2
$382K Sell
4,131
-295
-7% -$27.2K 0.04% 389
2024
Q1
$423K Sell
4,426
-681
-13% -$65.1K 0.05% 350
2023
Q4
$372K Sell
5,107
-503
-9% -$36.6K 0.05% 386
2023
Q3
$389K Buy
5,610
+114
+2% +$7.9K 0.05% 371
2023
Q2
$518K Sell
5,496
-84
-2% -$7.92K 0.07% 310
2023
Q1
$462K Buy
5,580
+406
+8% +$33.6K 0.06% 341
2022
Q4
$386K Sell
5,174
-2,250
-30% -$168K 0.06% 388
2022
Q3
$613K Buy
7,424
+53
+0.7% +$4.38K 0.09% 241
2022
Q2
$701K Buy
7,371
+51
+0.7% +$4.85K 0.09% 236
2022
Q1
$862K Sell
7,320
-1,339
-15% -$158K 0.1% 212
2021
Q4
$1.12M Sell
8,659
-127
-1% -$16.5K 0.12% 167
2021
Q3
$995K Buy
8,786
+154
+2% +$17.4K 0.12% 184
2021
Q2
$894K Buy
8,632
+120
+1% +$12.4K 0.11% 209
2021
Q1
$712K Buy
8,512
+51
+0.6% +$4.27K 0.09% 231
2020
Q4
$772K Buy
8,461
+1,200
+17% +$109K 0.11% 209
2020
Q3
$580K Sell
7,261
-208
-3% -$16.6K 0.09% 226
2020
Q2
$516K Buy
7,469
+344
+5% +$23.8K 0.09% 239
2020
Q1
$448K Sell
7,125
-6
-0.1% -$377 0.1% 226
2019
Q4
$555K Sell
7,131
-45
-0.6% -$3.5K 0.09% 252
2019
Q3
$526K Buy
7,176
+30
+0.4% +$2.2K 0.1% 247
2019
Q2
$440K Buy
7,146
+24
+0.3% +$1.48K 0.09% 268
2019
Q1
$454K Buy
7,122
+30
+0.4% +$1.91K 0.08% 252
2018
Q4
$362K Sell
7,092
-2,508
-26% -$128K 0.07% 278
2018
Q3
$557K Sell
9,600
-225
-2% -$13.1K 0.09% 233
2018
Q2
$477K Sell
9,825
-696
-7% -$33.8K 0.09% 250
2018
Q1
$489K Sell
10,521
-483
-4% -$22.4K 0.09% 243
2017
Q4
$413K Buy
+11,004
New +$413K 0.08% 288